Skip to content

Continuous monitoring of patients in and after the acute admission ward to optimize clinical pathways

Continuous monitoring of patients in and after the acute admission ward to optimize clinical pathways - Optimal Acute Admission Ward (Optimal-AAW)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51219
Enrollment
800
Registered
2021-07-21
Start date
2021-09-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patiënten die voor verschillende redenen op de acute opname afdeling komen patients in the Acute Admission Ward

Interventions

Continuous monitoring will be done by means of a wearable patch (Healthdot) that measures vital signs including heart rate and respiratory rate, posture and level of overall physical activity.

Sponsors

Rijnstate Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients admitted to the Acute Admission Ward of Rijnstate hospital, of whom it is unknown whether they should be discharged home or admitted to the hospital, are included in this randomized controlled study. In order for a patient to be eligible to participate in this study, the following criteria need to be met: • admitted to the AAW • Age >= 18 years • Able to speak and read Dutch • Willing and able to provide written informed consent

Exclusion criteria

Exclusion criteria: A patient who meets any of the following criteria will be excluded from participation: • Not able or willing to wear a wearable sensor on the chest continuously for 14 days • Planned major surgery in the upcoming 30 days • At the time of AAW admission already known to be discharged home or admitted to the hospital • Any skin condition, for example prior rash, discoloration, scars, infection, injury or open wounds at the area (Left lower rib) where the sensor needs to be placed • Known sensitivity to medical adhesives • Wearing an active implantable device (e.g. ICD, pacemaker) • Intend to go to the sauna or go swimming in the upcoming 14 days • Pregnant or breastfeeding • Use of creams or lotions that are known to influence the skin at the area where sensor is placed (such as medical and non-medical creams or lotions)

Design outcomes

Primary

MeasureTime frame
Study endpoints: The primary endpoint is the number (%) of patients discharged home from acute admission ward.

Secondary

MeasureTime frame
Secondary endpoints are length of stay in the acute admission ward and length of stay in the in-hospital wards, the number (%) of Rapid Response Team calls, Intensive Care Unit admissions and unplanned readmissions to the hospital

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)